Illumina NovaSeq series of sequencing systems
The NovaSeq series of systems leverage Illumina next-generation sequencing (NGS) technology. They offer users scalable throughput and flexibility for virtually any sequencing method, genome or scale of project.
Applications requiring large amounts of data, such as human whole genome sequencing (WGS), ultradeep exome sequencing and tumour–normal profiling, can be completed using the series. The same instrument can be used for less data-intensive methods, such as targeted resequencing. Every project, regardless of the size or goal, will benefit from simple load-and-go operation, integrated onboard cluster generation and seamless integration with data storage and analysis tools that help streamline the overall experimental workflow.
Available in two configurations, the NovaSeq 6000 offers tunable outputs up to 6 Tb and 20 billion reads in ~2 days, while the NovaSeq 5000 generates up to 2 Tb and 1.6 billion reads of data in ~2.5 days. Multiple flow cell types and read length combinations enable further output and run time configurations based on project needs, enabling sequencing with rapid results for a wide range of applications.
For more information: https://www.illumina.com/systems/sequencing-platforms/novaseq.html.
Phone: 03 9212 9900
Cayman Chemical has a complete range of assay kits to measure direct and indirect biomarkers of...
CHROMagar Y.enterocolitica for detection and differentiation of pathogenic Yersinia enterocolitica strains
CHROMagar has launched an updated version of CHROMagar Y.enterocolitica, with improved...
Merck's portfolio of 3 to 2000 L Mobius single-use bioreactors delivers flexibility and...